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ABSTRACT The phosphoprotein (NS) of vesicular stoma-
titis virus is an indispensable subunit of the vinrion-associated
RNA polymerase (L). NS consists of a highly acidic NH2-
terminal domain and a basic COOH-terminal domain. Unlike
the latter, the amino acid sequences of the NH2-terminal
regions are highly dissimilar among different viral serotypes,
although they share structural similarities. We have cloned an
NS gene into the SP6 transcription vector and replaced the
5'-terminal 80% by a full-length gene for fi-tubulin, which
contains an acidic COOH-terminal domain. Here we present
evidence that the chimeric tubulin-NS protein is biologically
active and that the acidic region in tubulin directly affects the
transcription reaction. These observations indicate that NS
probably functions as an activator protein in which the acidic
domain stimulates transcription of the viral genes by interact-
ing with the RNA polymerase as observed for eukaryotic
cellular transcription activators.
An RNA-dependent RNA polymerase packaged within the
purified virion of vesicular stomatitis virus (VSV) transcribes
the negative-strand genome RNA in vitro into five distinct
mRNAs and a leader RNA (1, 2). This transcription is
essential for initiation of infection when VSV infects cells.
The RNA polymerase consists of two distinct polypeptide
subunits: a large polypeptide, L, of 240 kDa and a small
phosphoprotein, NS, of 29 kDa tightly associated with each
other and also with the N protein-RNA template (N-RNA
template). There are approximately 50 molecules of the L
protein and 500 molecules of the NS protein per virion (3).
The unique feature of the VSV transcription complex is that
each of the reacting components can be separated free from
the others and in vitro RNA synthesis can be restored
effectively when L and NS proteins are added to the N-RNA
template (4).
By using the above transcription reconstitution system, it
was shown (5) that the L protein, which acts catalytically in
the initiation of RNA chains, fails to synthesize full-length
RNA unless the NS protein, which acts stoichiometrically, is
added to the transcription mixture. These results indicated
that the L protein is the RNA polymerase whereas the NS
protein is a regulatory protein that plays a role in the
transcription process, possibly by interacting with the N-
RNA template to facilitate access ofL protein to the genome
template forRNA synthesis (5, 6). Phosphorylation ofthe NS
protein seems to have important regulatory effect(s) in this
process (1).
To study the precise function of the NS protein in the
transcription process, we (7) inserted a full-length NS gene
(New Jersey serotype) into an SP6 transcription vector. This
system enabled us to obtain NS mRNA in amounts that,
when subsequently translated in vitro, resulted in the syn-
thesis of biologically active protein. The latter activity was
demonstrated by transcription reconstitution with purified L
protein and the N-RNA template. Systematic deletion map-
ping studies (7) showed (i) that the COOH-terminal basic 27
amino acids (Fig. 1, domain III) are not involved in tran-
scription but are essential for binding to the N-RNA template
in the absence of the L protein and (ii) that the adjacent 34
amino acids (domain II) interact with the L protein and are
directly involved in the transcription process. The phospho-
rylation ofthe invariant serine residues (Ser-236 and Ser-242)
in domain II plays an important role in its capacity to bind to
the L protein leading to RNA synthesis in vitro (8).
The negatively charged NH2-terminal half of the NS
protein (domain I) presumably is involved in some step(s) in
the RNA synthetic process. This domain is remarkably
dissimilar in amino acid sequence yet structurally similar
among VSV serotypes (9-11). Recently, we subcloned the
region containing domains II and III in the SP6 transcription
vector and demonstrated that the encoded polypeptide
(termed EB NS protein) binds to the L-N-RNA complex but
fails to support transcription. However, it does support
transcription when the polypeptide encoded by domain I is
added in trans (12). The intriguing observation was that
tubulin, which has acidic amino acid residues clustered at the
COOH-terminal region (13), was able to replace NS domain
I for RNA synthesis. We chose tubulin because it was
previously shown (14) to function as a positive transcription
factor for VSV as well as for Sendai, another negative-strand
RNA virus. In addition, tubulin associates with the L protein
in VSV-infected cells and, more important, anti-tubulin
antibody virtually abolishes in vitro RNA synthesis by
purified virions (14). These results indicated that tubulin,
perhaps specifically due to its acidic character, has a role in
the VSV transcription process. In this communication we
demonstrate that a chimeric protein containing B-tubulin
fused to domains II and III of the NS protein functions
efficiently for in vitro transcription. Further, the acidic
domain of tubulin in the chimeric polypeptide plays a direct
role in the transcription process.
MATERIALS AND METHODS
Construction of pGEM Tubulin Clone (pGEM-Tub). A
full-length cDNA clone of 8-tubulin in pBR322 plasmid at the
unique EcoRI site (13) was digested with EcoRI (Boehringer
Mannheim). The resulting insert was purified by 0.8% agar-
ose gel electrophoresis and the DNA was eluted from the gel.
The eluted insert DNA was purified by phenol/chloroform
extraction followed by ethanol precipitation and was dis-
solved in 1 mM Tris-HCI, pH 7.5/0.1 mM EDTA. Two
hundred nanograms of the insert was ligated with 200 ng of
EcoRI-cut, phosphatase-treated plasmid pGEM-4 by using
phage T4 DNA ligase (0.1 unit) in ligase reaction buffer [50
Abbreviation: VSV, vesicular stomatitis virus.
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FIG. 1. Diagram of the functional domains of the NS protein of VSV serotype New Jersey. The protein (274 amino acids) encoded by the
full-length NS gene (New Jersey serotype) was divided into three domains (7). The dashed lines within domain I represent acidic amino acid
residues. Solid circles represent constitutively phosphorylated residues, and open circles represent the potential phosphorylation sites conserved
between Indiana and New Jersey serotypes (9, 10). Two invariant serine residues (S) within domain II are shown (8).
mM Tris-HCl, pH 7.6/10 mM MgCl2/5% (wt/vol) polyeth-
ylene glycol 8000/1 mM ATP/1 mM dithiothreitol] in a total
volume of 20 1.d The reaction mixture was incubated at 80C
for 16 hr. The ligation mixture was then diluted 1:5 and used
to transform competent Escherichia coli RR1 cells. Positive
transformants were confirmed by restriction enzyme diges-
tion and dideoxy sequencing of the junction region according
to the Promega Biotec protocol (Promega Biotec, Madison,
WI).
Construction of pGEM Chimeric Plasmids. pGEM-Tub (10
,ug) was digested completely with Stu I and Sal I to remove
the 300-base-pair segment representing the noncoding part of
the tubulin gene and a portion ofthe pGEM polylinker region.
pGEM-EBNS has two Ava II sites, at positions 11 and 51.
pGEM-EBNS was partially digested withAva Il, blunt-ended
with Klenow polymerase, and then digested with Sal I.
Theoretically, two different fragments are possible (see Fig.
4). The large Stu I-Sal I fragment ofpGEM-Tub (300 ng) was
then ligated with 10 ng of Sal I-cut, blunt-ended smaller
fragments of pGEM-EBNS in a 20-pL reaction mixture. The
ligation reaction was carried out at 230C for 4 hr and then
stopped by the addition of 1 A.l of 0.5 M EDTA. The ligation
mixture was diluted 1:5 and then used to transform compe-
tent RR1 cells. The positive transformants of pGEM-Teb4
and pGEM-Tebl were then scored by sequencing the tubu-
lin-NS junction region according to the Promega Biotec
dideoxy sequencing protocol. Both pGEM-Teb4 and pGEM-
Tebl contain nucleotides 1-1405 of the tubulin gene. pGEM-
Teb4 contains nucleotides 564-894 of the NS gene, which
results in a + 1 shift in reading frame. pGEM-Tebl contains
-zATG Bam HI Stul TAA
(76) (1106) (1404) (1408)
NH- COOH
TUBULIN (444aa) (44aa)
nucleotides 604-894 ofthe NS gene, in frame with the tubulin
gene.
In Vitro Transcription of Recombinant Plasmids, Transla-
tion of mRNAs, and Reconstitution of VSV RNA Synthesis.
The recombinant plasmid pGEM-Tub (10 gg) was linearized
by digestion with BamHI or Sal I restriction enzyme. For the
chimeric plasmids pGEM-Tebl and pGEM-Teb4 (10 pg), the
DNAs were linearized prior to SP6 transcription by digestion
with Sal I. For control NS protein (BamHI NS), pGEM-NS
was digested with BamHI before the in vitro transcription
reaction. In vitro transcription reactions were performed with
the Riboprobe system (Promega Biotec) by following exactly
the manufacturer's protocol (7). Approximately 2 jug ofRNA
was obtained per Ag of linearized DNA. In vitro translation
of mRNAs was carried out in rabbit reticulocyte lysate (7).
Transcription-reconstitution reactions using in vitro synthe-
sized proteins in the presence of purified L protein, N-RNA
template, and EB NS protein were carried out as detailed
(12).
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FIG. 2. Schematic representation of the constructed pGEM-Tub
plasmid, including the important restriction sites. The construction
ofthe pGEM tubulin clone is detailed in Materials and Methods. The
plasmid, pGEM-Tub, has a single BamHI site, in the 3'-terminal
region ofthe tubulin coding sequence; cleavage at this site essentially
removes the COOH-terminal region containing the negatively
charged 44 amino acids (black box). Nucleotide positions of the
initiation and termination codons and theBamHI and Stu I restriction
sites are given below the stippled bar representing the tubulin cDNA.
FIG. 3. Transcription (Left) and translation (Center) of full-length
and truncated tubulin mRNAs and in vitro transcription reconstitution
(Right). The tubulin (Sal I) and its truncated version (BamHI) were used
to reconstitute transcription in the presence of purified L protein, N-
RNA template, and EB NS protein in a total volume of 200 tul, with[a-32P]CTP as the labeled precursor as detailed previously (8). The
RNA products synthesized in 2 hr were analyzed by 5% PAGE, with
7 M urea for mRNA, and autoradiography. Migration positions of
mRNAs coding for VSV G, N, NS, and M proteins are shown.
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FIG. 4. Construction ofpGEM plasmids containing part of the tubulin gene and the region of the NS gene encoding protein spanning domains
II and lII. Details of the strategy for the construction of the tubulin-NS chimeric gene are described in Materials and Methods.
RESULTS
Trans-activation of Transcription by in Vitro Translated
,8-Tubulin. To ascertain the exact role of the polypeptide
encoded by domain I, a recombinant plasmid was con-
structed containing the f-tubulin gene linked at its 3' end with
the NS gene sequence coding for domains II and III.
However, before we embarked on the construction of a
chimeric gene, it was important to demonstrate that clonally
expressed tubulin functions in trans as previously demon-
strated forf-tubulin purified from bovine brain (12, 14). The
full-length cDNA clone of mouse f3-tubulin isotype MP5,
derived from a cDNA library prepared from mRNA isolated
from mouse testis (13), was subcloned into pGEM-4 vector at
the EcoRI site behind the SP6 promoter (Fig. 2). The plasmid
pGEM-Tub, containing the full-length ,8-tubulin gene, would
yield tubulin polypeptide (444 amino acids) upon transcrip-
tion followed by translation of the mRNA in vitro. Digestion
with BamHI, however, would result in truncation of the gene
and loss of the region coding for the negatively charged
COOH-terminal domain of tubulin. The plasmid pGEM-Tub
was linearized by digestion with BamHI or Sal I and
transcribed. The resulting mRNAs, analyzed by PAGE,
migrated at the expected rates (Fig. 3, Left). The runoff
transcription products were then translated in vitro with
rabbit reticulocyte lysate to synthesize sufficient amounts of
full-length and truncated B3-tubulin for further studies (Fig. 3,
Center). These proteins were then used in place of domain I
in a transcription-reconstitution reaction containing purified
L protein and N-RNA template (Fig. 3, Right). The full-
length tubulin (from the Sal I-treated template) stimulated
RNA synthesis by 10-fold over background (second lane from
left) and was 30% as active in supporting transcription as the
control reaction containing in vitro expressed NS protein
(BamHI NS). The extent of RNA synthesis with the control
expressed protein was z70% of that when NS purified from
virions was used under identical condition (7). In striking
contrast, when the negatively charged carboxyl-terminal 44
amino acids were removed (BamHI tubulin), the polypeptide
was virtually inactive in the transcription reaction. These
results demonstrate that pGEM-Tub-derived polypeptide is
functionally active and that the acidic part of domain I plays
a major role in stimulating transcription of the genome RNA.
Construction of Tubulin-NS Chimeric Gene. We next con-
structed a chimeric clone containing the ,3-tubulin gene linked
to the sequence encoding domains II and III of NS (pGEM-
EBNS) (Fig. 4). The plasmid, pGEM-Tebl, contains the
sequences of domains II and III of the NS gene linked to the
tubulin gene such that the expressed chimeric protein (Tebl)
will be initiated at the 5' AUG codon of the tubulin mRNA
and terminate in frame. On the other hand, in the pGEM-
Teb4 construct the NS polypeptide region (domains II and
III) is out of frame in the chimeric protein (Teb4). The
expressed chimeric proteins were then tested for biological
activity by transcription-reconstitution reactions (Fig. 5).
Tebl chimeric polypeptide stimulated RNA synthesis by
20-fold over the reaction mixture containing L protein plus
N-RNA only. It supported transcription at 65% with respect
to the control reaction containing the full-length in vitro
expressed NS protein (BamHI NS). In contrast, Teb4 chi-
meric polypeptide failed to support RNA synthesis in vitro.
These results support the contention that domain I of the NS
protein can be replaced by an unrelated but similarly charged
polypeptide without abolishing its activity. Poly(glutamic
acid), but not polylysine, can also support transcription,
albeit less effectively (20% of control), when it replaces
domain I of the NS protein (Fig. 5). By contrast, domains II
and III of the NS protein govern the specificity of its
interaction with the template and L protein. From these
results it appears that the acidic property of domain I plays
a crucial role in allowing the RNA polymerase complex to
transcribe the N-RNA template.
Finally, we wished to determine the efficiency of transcrip-
tion activation by tubulin when added in trans compared to
the tubulin-NS chimeric protein. Stimulation of in vitro
transcription increased with increasing amounts of either
type of protein (Fig. 6); however, the chimeric protein Tebl
stimulated RNA synthesis to 65% of control, whereas RNA
Stu I, Sal
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FIG. 5. Transcription reconstitution in vitro with chimeric pro-
teins. The tubulin-NS chimeric proteins encoded in pGEM-Teb4 and
pGEM-Tebl were synthesized in vitro and used to reconstitute
transcription in the presence of purified L protein and N-RNA
template in a total volume of 200 ,ul (7). Poly(glutamic acid) (10 /Ag) or
polylysine (10 ,ug) was also used to reconstitute transcription in
presence of EB NS, L protein, and N-RNA template. The [a-
32P]CMP-labeled RNA synthesized in 2 hr was analyzed as described
(12). Migration positions ofmRNAs coding for VSV G, N, NS, and M
proteins are shown.
synthesis reached only 30% of the control value for tubulin
added in trans. These results indicate that the acidic domain
functions more efficiently when linked to the NS-protein
domains II and III, which correspond to the binding sites for
the template and polymerase, respectively.
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DISCUSSION
The data presented here provide a better understanding ofthe
structure and possible function(s) of the highly acidic NH2-
terminal region of the NS phosphoprotein of VSV. By itself,
this segment of the polypeptide is inactive in the transcription
process; however, when added in trans with the polymerase-
and template-binding regions (domains II and III), the bio-
logical activity of the phosphoprotein is effectively restored
(12). Here, we demonstrate that the acidic domain can be
intramolecularly substituted by tubulin, a similarly charged
protein (Figs. 4 and 5). Thus, a tubulin-NS chimeric protein
that contains only 18% of the NS sequence retains most of its
biological activity (Fig. 5). These results indicate that the
nucleotide sequence of the NS gene encoding domain I can
undergo substantial alteration and mutation during evolution
so long as it retains a negative charge character in the
polypeptide. This probably explains the high mutability of the
NS domain I within vesiculoviruses (11). By contrast, the
carboxyl-terminal sequence encoding domains II and III has
withstood evolutionary pressure, presumably because it
imparts specificity for interaction of NS protein with the
template and L protein. This is reflected in the high degree of
amino acid sequence identity within the COOH-terminal
portion among the NS genes ofthe different serotypes (9-11).
It is noteworthy that tubulin-NS chimeric protein is more
effective in supporting transcription (65% of control) than
tubulin added in trans with NS domains II and III (30%; Fig.
6). These results indicate that the NS gene has evolved to link
domain I with the COOH-terminal conserved domain for
efficient transcription of the genome RNA. The entire struc-
ture of the polypeptide must interact with the reacting
components to enhance the transcription process.
An important observation is that poly(glutamic acid) can
also activate transcription, although poorly, when added in
trans (Fig. 5). Similarly, the COOH-terminal 44 amino acids
of tubulin, containing clusters of acidic residues, appear to be
directly involved in the transcription process, because their
removal abrogates RNA synthesis in vitro (Fig. 3). Removal
of that domain from tubulin did not alter the net negative
charge of the protein (pI change, 5.14 to 5.15). This indicates
that a stretch or cluster of acidic amino acids of variable
length in domain I provides the necessary and sufficient
condition to impart a trans-activating property to the NS
protein. The stimulation of in vitro RNA synthesis by tubulin
observed by Moyer et al. (14) may have been due to
interaction of the acidic domain of tubulin with the N-RNA
template. Microtubule-associated proteins have also been
shown to act as transcription factors in VSV RNA synthesis
l000/.
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FIG. 6. Transcription reconstitu-
tion in vitro with tubulin or tubulin-
NS protein. Transcription reconstitu-
tion in standard reaction mixtures
65% was carried out in the presence of
purified L protein, N-RNA template,
60 pg of EB NS protein, and various
concentrations of 18-tubulin (100
pg/,ul of reticulocyte lysate). Acid-
insoluble radioactivity was deter-
mined after 2 hr of RNA synthesis at
300C (hatched bars). Similar reactions
were carried out with various concen-
trations of Tebl protein (120 pg/,ul of
reticulocyte lysate) (solid bars). RNA
synthesis for 2 hr by virion-purified L
protein, in vitro expressed NS protein
(BamHI NS), and N-RNA template
(open bar) was taken as 100%o. Reac-
tion conditions were as described (8).
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in vitro (15). Whether this multiprotein complex, like tubulin,
functions as negatively charged proteins in the activation of
VSV RNA polymerase or has another role in the life cycle of
VSV remains to be seen. Involvement of the cytoskeleton
complex in the biosynthesis of VSV proteins has also been
documented (16-18).
The above structural and functional features of the NS
protein bear a striking resemblance to those of the yeast
transcriptional regulator proteins GAL4 and GCN4 (19, 20).
These proteins contain two distinct functional domains: one
binds DNA and the other is an acidic region that functions as
the transcription activator. The former domain binds at
sequence-specific sites on the DNA template (upstream
activator sequence) but fails to activate transcription,
whereas the latter, acidic fragment activates transcription
even when substituted by unrelated but acidic E. coli proteins
or synthetic amphipathic peptide (21, 22). Recently, the
DNA-binding portion of E. coli LexA repressor protein was
fused to v-fos and c-fos oncogene products (which are
acidic), and the resulting chimeric proteins activated yeast
gene expression only when the LexA operator was inserted
next to the promoter sequence (23). Interestingly, yeast
trans-activators have also been shown to activate mouse
mammary tumor virus promoter in mammalian cells when
GAL4 binding sites are present before the promoter (24). In
addition, chimeric protein consisting of the human estrogen
receptor DNA-binding domain and either GAL4 or GCN4
activating acidic regions can activate a promoter region
controlled by an estrogen-responsive enhancer (25). All ofthe
above-mentioned acidic trans-activators characteristically
contain stretches of a-helical structures (22).
The VSV phosphoprotein NS, like yeast trans-activator
proteins, contains two distinct regions: a specific template-
and polymerase-binding region (domains II and III) and an
acidic region (domain I) that constitutes the major portion of
the polypeptide. Based on the structural and functional
similarities between the NS protein and the eukaryotic
trans-activators, it is tempting to speculate that the NS
protein also functions as a transcriptional activator in the
RNA-dependent RNA transcription process in the VSV
system. NS plays a crucial role in orchestrating the formation
of an active transcription initiation complex with the L
protein and the N-RNA template. The basic COOH-terminal
region (domains II and III) binds to the L protein and links at
a specific site(s) on the N-RNA template. However, this
complex remains transcriptionally inactive until activated by
the acidic domain I. The precise nature of this complex
interaction remains to be understood. The acidic domain I,
like the eukaryotic transcriptional activators, contains
stretches of a-helical structures (18, 26). These structures
probably interact with the helical structures of the N-RNA
template and transiently displace the RNA-bound N protein,
allowing the L protein to contact the genome RNA. The
putative RNA binding sites of the NS protein on the genome
template remain to be precisely determined, although a high-
affinity binding site at the 3' end of the genome RNA has been
reported (27). Thus, the molecular mechanism underlying
transcriptional activation may be conserved in a large variety
of eukaryotic species including RNA viruses.
We are grateful to Dr. N. Cowan (New York University Medical
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